In accordance with the applicable requirements and regulations of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and other applicable Regulations, Eris Lifesciences has informed that it enclosed the schedule of Analyst / Institutional Investor Meeting as on September 26, 2023.
The above information is a part of company’s filings submitted to BSE.